Physician profile
Mark J Tenholder
NPI 1407850878
$2,258.55
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $110 · 2021: $785 · 2022: $57.94 · 2023: $626 · 2024: $342 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $956.60 | 2019-2025 | Rosa, Continuum, Persona |
| Stryker Corporation | $263.28 | 2020-2023 | Mako |
| Dynasplint Systems INC. | $245.22 | 2021 | |
| Smith+Nephew, INC. | $228.52 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Djo, LLC | $141.65 | 2023 | Cmf |
| Kuros Biosciences USA, INC | $116.83 | 2023 | |
| Bioventus LLC | $76.66 | 2022-2025 | Durolane, Durolane |
| Becton, Dickinson and Company | $41.01 | 2022 | |
| Si-Bone, INC. | $39.91 | 2020-2024 | |
| Depuy Synthes Sales INC. | $39.19 | 2019-2023 | Orthovisc, Monovisc |
| Aroa Biosurgery Incorporated | $25.48 | 2019 | |
| Ethicon US, LLC | $21.02 | 2025 | Vistaseal |
| Pacira Pharmaceuticals Incorporated | $19.36 | 2023 | Exparel, Zilretta, Iovera |
| Cgg Medical INC | $16.80 | 2024 | |
| Surgalign Spine Technologies, INC. | $15.78 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Tenholder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.